Morphogen Pharmaceuticals, Inc.
Records under this name other than patents Morphogen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Morphogen Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,066,385 | Information Processing Terminal or Control Method Therefor Formerly held Term ended Term ended May 6, 2023 · High confidence | Term ended | Term ended May 6, 2023 | High confidence |
| US 9,617,513 | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof Formerly held Term ended Ended no later than Sep 24, 2019 · USPTO record | Term ended | Ended no later than Sep 24, 2019 | USPTO record |
| US 6,214,369 | Mesenchymal stem cells for cartilage repair Formerly held Term ended Term ended May 6, 2019 · USPTO record | Term ended | Term ended May 6, 2019 | USPTO record |
| US 6,024,253 | Container including bottle for holding liquid and tube for holding a dropper Formerly held Term ended Term ended Mar 29, 2019 · USPTO record | Term ended | Term ended Mar 29, 2019 | USPTO record |
| US 5,827,735 | Pluripotent mesenchymal stem cells and methods of use thereof Formerly held Term ended Term ended no later than Oct 27, 2018 · Low confidence | Term ended | Term ended no later than Oct 27, 2018 | Low confidence |
| US 5,906,934 | Mesenchymal stem cells for cartilage repair Formerly held Term ended Term ended no later than May 25, 2019 · Low confidence | Term ended | Term ended no later than May 25, 2019 | Low confidence |